Skip to Content

Xelpros Approval History

FDA Approved: Yes (First approved September 12, 2018)
Brand name: Xelpros
Generic name: latanoprost
Dosage form: Ophthalmic Emulsion
Company: Sun Pharmaceutical Industries Inc.
Treatment for: Glaucoma, Open Angle, Intraocular Hypertension

Xelpros (latanoprost) is a prostaglandin F analog indicated for reduction of elevated intraocular pressure in patients with open-angle glaucoma, or ocular hypertension.

Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium chloride (BAK), a preservative commonly used in topical ocular preparations.

Development History and FDA Approval Process for Xelpros

DateArticle
Sep 14, 2018Approval FDA Approves Xelpros (latanoprost ophthalmic emulsion) to Treat Open-angle Glaucoma or Ocular Hypertension

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide